What Happened?
Waltham, MA-based Kala Pharmaceuticals Appointed Charles McDermott as Executive Vice President of Business Development
About the Company
Kala Pharmaceuticals, Inc. (Kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases.
About the Person
Charles McDermott is Executive Vice President of Business Development at Kala Pharmaceuticals. Previously, Charles held various senior HR leadership roles in the industry.
Info Source
Press Release
Short Profile